How to Cite
Abstract
The results of treatment of gastric cancer with peritoneal dissemination are not very comforting. The average life expectancy of patients after diagnosis is less than 6 months. Methods of systemic treatment are ineffective. The most effective strategy is regional treatment, a special place in recent years has taken intraperitoneal chemotherapy with low-dose Cisplatin and Doxorubicin administered as a pressurized aerosol (PIPAC). This article presents the analysis of the first results of treatment of patients with gastric cancer with peritoneal carcinomatosis, which was used PIPAC at conventional regimens (standard for this technique, low-dose cytostatics, exposure time and intraperitoneal pressure) and in the experimentally developed effective regimen. The developed PIPAC regimen proposed by the authors proved its safety and objectively more effective than the standard for such parameters as objective tumor response, histological response and overall survival of patients. The study will be continued to obtain statistically reliable results.References
Багненко С.Ф., Захаренко A.A., Натха А.С. и др. Клинико-экспериментальное обоснование эффективного режима лапароскопической аэрозольной внутрибрюшинной химиотерапии // Вестник хирургии им. И.И. Грекова. - 2017. - Т. 176. - № 2. - С. 95-99.
Захаренко А.А., Натха А.С., Беляев М.А. и др. Экспериментальное обоснование максимально эффективного режима лапароскопической аэрозольной внутрибрюшинной химиотерапии (PIPAC) // Вопросы онкологии. - 2017. - Т. 63. - № 3. - С. 490-496.
Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden ofcancer in 2008 // Int. J. Cancer. - 2010. - Vol. 127. - P 2893-2917.
Wagner A.D., Unverzagt S., Grothe W. et al. Chemotherapy for advanced gastric cancer // Cochrane Database Syst Rev. - 2010. - Vol. 17. - CD004064. - DOI: 10.1002/14651858
Yonemura Y., Endou Y., Sasaki T. et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer // Eur. J. Surg. Oncol. - 2010. - Vol. 36. - P. 1131-1138.
Sadeghi B, Arvieux C., Glehen O. et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study // Cancer. - 2000. - Vol. 88. - P. 358-363.
Thomassen I., van Gestel Y R., van Ramshorst B. et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors // Int. J. Cancer. -2014. - Vol. 134(3). - P. 622-628.
Esquis P., Consolo D., Magnin G. et al. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis // Ann Surg. - 2006. - Vol. 244. - P. 106-112.
Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Review // Nat. Rev. Cancer. - 2006. - Vol. 6. - P. 583-592.
Nadiradze G., Giger-Pabst U., Zieren J. et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis // J. Gastrointest. Surg. - 2016. - Vol. 20. - P. 367-373.
Girshally R., Demtrder C., Albayrak N. et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy // World J. Surg. Oncol. - 2016. - Vol. 14. - P. 253.
Khomyakov V., Ryabov A., Larisa V. et al. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis // Pleura and Peritoneum. - 2016. - Vol. 1(3). - P. 159-166.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018